Project Grant HT94252510332
Award Date
6/1/25
Completion Date
5/31/27
Dollars Obligated
$622K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Notre Dame, IN 46556, USA
Similar Awards
This federal Project Grant award of $250,000 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The funding will support research at the University of Notre Dame DU Lac aimed at "TARGETING NEURAL STEM CELL QUIESCENCE TO PROMOTE REMYELINATION", with a project period from September 1, 2024 to August 31, 2026. The research focuses on developing innovative approaches to address critical medical challenges facing military...
The federal Project Grant award, worth $1,339,955.00, was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The award supports advanced biomedical research focused on transforming healthcare for military service members and the general public. The primary awardee, the Research Institute at Nationwide Children's Hospital (RINCH), will conduct research to identify and circumvent resistance after donor-derived ex vivo...
This federal Project Grant, awarded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), provides $1,600,000.00 to Northwestern University to conduct research aimed at "Potentiating Long-Lived Antitumor Effector CD8+ T Cells for TNBC Therapy". The award, with a performance period from December 15, 2024 to December 14, 2027, will support advanced biomedical research focused on transforming healthcare for military...
The Regents of the University of California, San Francisco was awarded a $2,018,750 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from August 1, 2022 to July 31, 2025 to develop nano-CARS technology for the treatment of MLLR B-cell acute lymphoblastic leukemia. The Military Medical Research and Development program aims to transform military and public health...
The University of Southern California will receive $413,750 through September 2025 under a Project Grant from the Defense Health Agency to develop next-generation chimeric antigen receptor T cells targeting folate receptor 1 for the treatment of ovarian cancer. Funded through the Military Medical Research and Development program (CFDA 12.420), this award will support the grantee's applied medical research efforts to investigate innovative solutions for battlefield health care and transform...
The Defense Health Agency awarded a $602,814 Project Grant to the University of Nebraska Medical Center (UNMC) under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from November 1, 2024 to October 31, 2027, supports research to investigate "Targeting Extracellular Nucleoside Metabolism as a Strategy to Potentiate the Effects of Immunotherapy in Pancreatic Ductal Adenocarcinoma." The project aims to explore innovative approaches...
This federal Project Grant award of $808,141, issued by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports research targeting inflammatory pathways in breast cancer brain metastases. The award provides funding to Weill Medical College of Cornell University, a leading academic medical institution, to conduct research on using anti-VEGF ultrasmall particle therapy for the treatment of edema and radiation necrosis. The...
This $1,539,818.00 Department of the Army Medical Command federal Project Grant award under the Military Medical Research and Development program (CFDA 12.420) will fund research led by the Regents of the University of Minnesota to develop multiplex edited, dual CAR gamma delta T cells targeting pediatric solid tumors. The three-year project, with a performance period from November 15, 2024 to November 14, 2027, seeks to advance innovative cell-based immunotherapies for the treatment of...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program provides $1,612,104.00 to the University of Chicago to develop and evaluate senescent tumor cell-loaded dendritic cell vaccines for breast cancer research. The award period runs from February 1, 2025 to January 31, 2028. The University of Chicago, a renowned private research university, will leverage its expertise in medical research,...
This $1,100,633 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports cancer research and translational science initiatives at the University of North Carolina at Chapel Hill (UNC-CH). Specifically, the award will fund innovative biomedical research projects focused on transforming healthcare for military service members and the broader public. Research areas may include disease prevention, diagnosis, treatment, and...